Revian Appoints Erin Gomez as Regional Director, West Coast
Experienced sales leader to support regional growth and provider engagement
Gomez brings extensive experience in practice development, sales leadership and healthcare services, with a strong track record across competitive markets.
"Erin brings a strong ability to execute at the regional level and support our provider partners," said
As Regional Director, Gomez will lead growth initiatives across the
"Revian has built a strong foundation and there is significant opportunity to support providers and expand access across the
With continued investment in regional leadership like Erin, the company is well positioned to expand its presence and drive adoption across priority markets.
About Revian, Inc.
Revian, an operating subsidiary of KNOW Bio, LLC, is a medical technology innovator dedicated to stimulating the body's natural processes to rejuvenate skin and hair through patented therapies. Backed by scientific data and proven clinical results, Revian delivers effective, at-home treatments for men and women experiencing thinning hair. The company is committed to providing safe, evidence-based innovative solutions and partnering with healthcare providers to deliver meaningful outcomes. For more information, visit www.revian.com.
Contact: John Oakley, [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/revian-appoints-erin-gomez-as-regional-director-west-coast-302800682.html
SOURCE REVIAN, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C.
- Genye Technology Opens New LA-Area Branch and Technology Demonstration Center in Southern California
- Latest Crypto News: Bitcoin Rips Past $77K, Cardano Turns Bullish – Is Apeing Whitelist the Next Move for Traders?
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share